Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

PHASE3CompletedINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

November 11, 2022

Study Completion Date

February 21, 2023

Conditions
Prurigo Nodularis
Interventions
DRUG

Nemolizumab 30 mg

Participants received either 30 mg or 60 mg dose of nemolizumab as SC injection.

DRUG

Placebo

Participants received matching placebo as SC injection.

Trial Locations (100)

1036

Galderma Investigational Site, Budapest

1220

Galderma Investigational Site, Vienna

2900

Galderma Investigational Site, Hellerup

4020

Galderma Investigational Site, Linz

5000

Galderma Investigational Site, Szolnok

5700

Galderma Investigational Site, Gyula

6000

Galderma Investigational Site, Kecskemét

6720

Galderma Investigational Site, Szeged

8036

Galderma Investigational Site, Graz

8200

Galderma Investigational Site, Aarhus

8900

Galderma Investigational Site, Zalaegerszeg

10065

Galderma Investigational Site, New York

10117

Galderma Investigational Site, Berlin

16132

Galderma Investigational Site, Genova

17176

Galderma Investigational Site, Solna

19103

Galderma Investigational Site, Philadelphia

19104

Galderma Investigational Site, Philadelphia

20246

Galderma Investigational Site, Eppendorf

20537

Galderma Investigational Site, Hamburg

21231

Galderma Investigational Site, Baltimore

22031

Galderma Investigational Site, Fairfax

23538

Galderma Investigational Site, Lübeck

24105

Galderma Investigational Site, Kiel

24128

Galderma Investigational Site, Vicenza

26133

Galderma Investigational Site, Oldenburg

27262

Galderma Investigational Site, High Point

27617

Galderma Investigational Site, Raleigh

31217

Galderma Investigational Site, Macon

31904

Galderma Investigational Site, Columbus

33021

Galderma Investigational Site, Hollywood

33028

Galderma Investigational Site, Pembroke Pines

33125

Galderma Investigational Site, Miami

33484

Galderma Investigational Site, Delray Beach

33607

Galderma Investigational Site, Tampa

33770

Galderma Investigational Site, Largo

35233

Galderma Investigational Site, Birmingham

35244

Galderma Investigational Site, Birmingham

37075

Galderma Investigational Site, Göttingen

37909

Galderma Investigational Site, Knoxville

40225

Galderma Investigational Site, Düsseldorf

41124

Galderma Investigational Site, Modena

43126

Galderma Investigational Site, Parma

44106

Galderma Investigational Site, Cleveland

48109

Galderma Investigational Site, Ann Arbor

48149

Galderma Investigational Site, Münster

48455

Galderma Investigational Site, Bad Bentheim

52074

Galderma Investigational Site, Aachen

53105

Galderma Investigational Site, Bonn

55131

Galderma Investigational Site, Mainz

60044

Galderma Investigational Site, Lake Bluff

60613

Galderma Investigational Site, Chicago

63110

Galderma Investigational Site, St Louis

64283

Galderma Investigational Site, Darmstadt

64506

Galderma Investigational Site, Saint Joseph

66100

Galderma Investigational Site, Chieti

66614

Galderma Investigational Site, Topeka

67100

Galderma Investigational Site, L’Aquila

69115

Galderma Investigational Site, Heidelberg

72076

Galderma Investigational Site, Tübingen

73071

Galderma Investigational Site, Norman

77401

Galderma Investigational Site, Bellaire

78401

Galderma Investigational Site, Laredo

78738

Galderma Investigational Site, Austin

80131

Galderma Investigational Site, Napoli

80337

Galderma Investigational Site, Münich

80802

Galderma Investigational Site, Münich

84117

Galderma Investigational Site, Salt Lake City

84663

Galderma Investigational Site, Springville

86179

Galderma Investigational Site, Augsburg

90045

Galderma Investigational Site, Los Angeles

91054

Galderma Investigational Site, Erlangen

92121

Galderma Investigational Site, San Diego

92130

Galderma Investigational Site, San Diego

94404

Galderma Investigational Site, Santa Monica

95123

Galderma Investigational Site, Catania

95815

Galderma Investigational Site, Sacramento

97080

Galderma Investigational Site, Würzburg

02919

Galderma Investigational Site, Johnston

02903

Galderma Investigational Site, Providence

T3E OB2

Galderma Investigational Site, Calgary

N6A 3H7

Galderma Investigational Site, London

S7K OH6

Galderma Investigational Site, Saskatoon

01307

Galderma Investigational Site, Dresden

06120

Galderma Investigational Site, Halle

06129

Galderma Investigational Site, Perugia

00144

Galderma Investigational Site, Roma

00168

Galderma Investigational Site, Roma

42-202

Galderma Investigational Site, Częstochowa

80-382

Galderma Investigational Site, Gdansk

81-537

Galderma Investigational Site, Gdynia

40-040

Galderma Investigational Site, Katowice

90-127

Galderma Investigational Site, Lodz

60-702

Galderma Investigational Site, Poznan

30-055

Galderma Investigational Site, Rzeszów

01-192

Galderma Investigational Site, Warsaw

50-381

Galderma Investigational Site, Wroclaw

DY1 2HQ

Galderma Investigational Site, Dudley

G3 8SJ

Galderma Investigational Site, Glasgow

SE1 9RT

Galderma Investigational Site, London

NE1 4LP

Galderma Investigational Site, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY